Treatment of Ulcerative Colitis by Cationic Liposome Delivered NLRP3 siRNA.

Jing HuangMengmeng DaiMingxia HeWeicheng BuLiwen CaoJing JingRun Cao Hailong Zhang Ke Men

Published in: International journal of nanomedicine (2023)

We introduced a prospective approach for the efficient delivery of siRNA in vitro and in vivo with high safety and stability, which was found to have great potential in treating NLRP3-driven diseases in an RNA-silencing manner.

Keyphrases

ulcerative colitis
cancer therapy
nlrp inflammasome
drug delivery
risk assessment
human health